In 10 patients with available matched tumor specimen and peripheral blood samples, significantly higher percentage of CD4 + FOXP3+ T-regulatory cells and lower ratio of CD8+/CD4 + FOXP3+ in the tumor compared with blood were reported. The gene discussed is CD4; the disease is neoplasm.